Riskpilot← Back to searchSign inGet full accessEkerö Djurklinik AB
ABActiveOrg 5569480741Bryggvägen 133Veterinary activities · NACE 7500Est. 20135 employees
Revenue 2024
SEK 8,9M
+43% vs 2023
EBITDA margin
22.0%
+46% vs 2023
Equity ratio
64.7%
Financial strength
Net profit 2024
SEK 1,5M
+48% vs 2023
| Revenue | SEK 8,9M | +43% |
| EBITDA | SEK 2M | +46% |
| Net profit | SEK 1,5M | +48% |
| Total assets | SEK 3,6M | +62% |
| Equity | SEK 2,4M | +43% |
| Employees | 5 | — |
Legal name
Ekerö Djurklinik AB
Org number
5569480741
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
6 november 2013
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva veterinärverksamhet.
Address
Bryggvägen 133
Phone
+46707977918
Email
info@ekerodjurklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 423 | 1 587 | 3 239 | 6 239 | 8 904 |
| Staff expenses | — | — | −1 204 | −2 422 | −4 042 |
| EBITDA | 180 | 885 | 160 | 1 346 | 1 962 |
| Depreciation & amort. | −29 | −29 | −36 | −54 | −45 |
| EBIT | 151 | 856 | 125 | 1 292 | 1 917 |
| Net financials | — | — | −1 | 3 | −4 |
| Profit before tax | 151 | 856 | 124 | 1 295 | 1 913 |
| Tax | −33 | −177 | −26 | −269 | −398 |
| Net profit | 118 | 679 | 97 | 1 026 | 1 515 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 763 | 1 011 | 1 354 | 2 256 | 3 648 |
| Equity | 606 | 917 | 827 | 1 647 | 2 362 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 156 | 94 | 528 | 610 | 1 286 |
| Total debt | 156 | 94 | 528 | 610 | 1 286 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20202024
Equity ratio
64.7%
This company
38.2%
Market median
+69% vs market
20202024
Return on equity
64.2%
This company
18.4%
Market median
+249% vs market
20202024
Net profit margin
17.0%
This company
8.1%
Market median
+110% vs market
20202024
Asset turnover
2.44×
This company
1.12×
Market median
+118% vs market
20202024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JL Audit | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ekerö Djurklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Louise Gentele | Audit | 0 companies |
| Jon Mikael Palmert | Chairman | 0 companies |
| Caroline Palmert | Board of Directors | 0 companies |
| Philip Wikberg | Deputy Board Member | 0 companies |